Pharmacokinetics of oral disopyramide phosphate in patients with renal impairment.
Open Access
- 1 September 1980
- journal article
- Published by Wiley
- Vol. 10 (3), 245-248
- https://doi.org/10.1111/j.1365-2125.1980.tb01751.x
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Long-term antihypertensive drug treatment and blood pressure control in three hospital hypertension clinics.Heart, 1980
- Role of concentration-dependent plasma protein binding in disopyramide dispositionJournal of Pharmacokinetics and Biopharmaceutics, 1979
- Pre- and postsynaptic α-adrenoceptor antagonism by indoramin in isolated tissues of the ratJournal of Pharmacy and Pharmacology, 1978
- Contribution of atenolol, bendrofluazide, and hydrallazine to management of severe hypertension.BMJ, 1977
- Beta blockade in essential hypertension: an analysis of response to oxprenolol.Heart, 1977
- EVALUATION OF BETA BLOCKADE, BENDROFLUAZIDE, AND PRAZOSIN IN SEVERE HYPERTENSIONThe Lancet, 1977
- A placebo controlled trial of the alpha-blocker, indoramin, in the treatment of arterial hypertensionCurrent Medical Research and Opinion, 1976
- Atenolol and bendrofluazide in hypertension.BMJ, 1975
- Some clinical pharmacological studies with indoramin, with observations on its therapeutic usefulnessPublished by Oxford University Press (OUP) ,1974
- The evaluation of the α-adrenoceptor blocking action of indoramin, phentolamine and thymoxamine on the rat and guinea-pig isolated mesenteric vasculature and aortic spiral preparationsJournal of Pharmacy and Pharmacology, 1973